What does this research mean for the field?

Question

Accepted Answer

While current management of HHT-related epistaxis relies on guideline-directed anti-fibrinolytic and antiangiogenic therapies with variable efficacy, emerging insights into inflammatory and angiogenic pathways are revealing novel therapeutic targets. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Epistaxis Prevention, Treatment, and Future Perspectives for Hereditary Hemorrhagic Telangiectasia

Discussion

Member takes

Overview

Key Points

Cite This Study